BlackRock Inc. Purchases Shares of 407,349 Nutex Health Inc. $NUTX

Key Points

• BlackRock acquired 407,349 Nutex Health shares during the second quarter, valued at approximately $69.6 million, giving it a 5.92% stake. Institutional investors and hedge funds collectively owned 5.32% of the company.
• Nutex Health reported quarterly earnings of $9.38 per share, beating the $4.95 analyst consensus, while revenue of $210.75 million came in slightly below expectations. The stock recently opened at $189.25, near its 12-month high of $204.
• Analyst sentiment remains favorable, with a consensus “Buy” rating and a $300 target price. Lake Street Capital and B. Riley issued buy ratings with targets of $310 and $290, respectively, while Zacks upgraded the stock to “strong buy.”

BlackRock Inc. purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 407,349 shares of the company's stock, valued at approximately $69,612,000. BlackRock Inc. owned 5.92% of Nutex Health at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Islay Capital Management LLC acquired a new stake in Nutex Health during the fourth quarter worth approximately $34,000. BNP Paribas Financial Markets boosted its holdings in shares of Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock worth $40,000 after buying an additional 290 shares in the last quarter. Royal Bank of Canada grew its position in shares of Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company's stock worth $59,000 after buying an additional 316 shares during the period. Bank of America Corp DE increased its stake in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after acquiring an additional 2,043 shares in the last quarter. Finally, EverSource Wealth Advisors LLC acquired a new position in shares of Nutex Health during the 1st quarter valued at $83,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Stock Performance

Shares of Nutex Health stock opened at $189.25 on Monday. The business's fifty day simple moving average is $171.62 and its 200 day simple moving average is $133.84. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. Nutex Health Inc. has a 12 month low of $77.21 and a 12 month high of $204.00. The firm has a market capitalization of $1.30 billion, a P/E ratio of 7.43 and a beta of 0.24.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts' consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The firm had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. As a group, analysts anticipate that Nutex Health Inc. will post 30.11 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on NUTX shares. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Monday, July 20th. Weiss Ratings raised Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, July 28th. Lake Street Capital reiterated a "buy" rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. B. Riley Financial started coverage on Nutex Health in a research note on Friday, June 26th. They issued a "buy" rating and a $290.00 price objective for the company. Finally, Zacks Research upgraded Nutex Health from a "hold" rating to a "strong-buy" rating in a report on Monday, August 24th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $300.00.

About Nutex Health

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.